Literature DB >> 24796853

A single pathophysiological pathway in Takotsubo cardiomyopathy: Catecholaminergic stress.

Elisabeth Coupez1, Romain Eschalier2, Bruno Pereira3, Romain Pierrard4, Géraud Souteyrand1, Guillaume Clerfond1, Bernard Citron4, Jean-René Lusson1, Nicolas Mansencal5, Pascal Motreff1.   

Abstract

BACKGROUND: Takotsubo cardiomyopathy (TTC) continues to be under-diagnosed, due to its varying presentation, with potentially serious consequences if treatment is delayed. AIMS: To demonstrate the consistent involvement of catecholaminergic stress in TTC, regardless of the trigger.
METHODS: Between 01 July 2009 and 31 August 2013, patients managed in our centre for thoracic pain syndrome, with or without troponin release, were followed up prospectively. TTC was diagnosed from the apical ballooning seen on left ventricular imaging (angiography or transthoracic echocardiography) in the absence of a significant coronary artery lesion. Triggers (emotional trauma, surgical stress and β2-mimetic intoxication) were recorded; catecholamine-secreting tumours were screened for with a urinary methoxylate-derivative assay.
RESULTS: TTC was diagnosed in 40 out of 2754 (1.5%) patients with thoracic pain syndrome, with or without troponin release. Triggers were emotional trauma (n=29, 72.5%), surgical stress (n=5, 12.5%), adrenergic intoxication (n=3, 7.5%) and catecholaminergic tumour (n=3, 7.5%). Mean left ventricular ejection fraction at admission was 38.0 ± 15.7%. Eight (20%) patients initially showed cardiogenic shock. In-hospital mortality was 7.5%, with no deaths from cardiogenic causes. Thirty-five (94.6%) of the survivors had recovered a normal left ventricular ejection fraction (> 55%) by discharge.
CONCLUSION: Whatever the trigger, the common denominator in TTC is catecholaminergic stress. Classically suggested after emotional trauma, TTC may also be induced by surgical stress or endogenous or iatrogenic β2-mimetic intoxication. The various contexts all have a similarly excellent cardiovascular prognosis if treated early.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Catecholamines; Catécholamine; Pheochromocytoma; Phéochromocytome; Takotsubo cardiomyopathy; Takotsubo cardiomyopathie

Mesh:

Substances:

Year:  2014        PMID: 24796853     DOI: 10.1016/j.acvd.2014.04.001

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  13 in total

Review 1.  Autonomic nervous system in Takotsubo syndrome.

Authors:  Sonia Borodzicz; Katarzyna Czarzasta; Grzegorz Opolski; Agnieszka Cudnoch-Jędrzejewska
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

2.  Funny Lumps, Flaming Pheo, and a Broken Heart: A Rare Case of Pheochromocytoma.

Authors:  Khurram Butt; Saeed Ali; Zeeshan Sattar; Asad Ur Rahman; Jeremy R Burt
Journal:  Cureus       Date:  2018-11-28

3.  Rare Variants in Cardiomyopathy Genes Associated With Stress-Induced Cardiomyopathy.

Authors:  M Yashar S Kalani; Ashley L Siniard; Jason J Corneveaux; Ryan Bruhns; Ryan Richholt; James Forseth; Joseph M Zabramski; Peter Nakaji; Robert F Spetzler; Matthew J Huentelman
Journal:  Neurosurgery       Date:  2016-06       Impact factor: 4.654

Review 4.  Epidemiology, pathogenesis, and management of takotsubo syndrome.

Authors:  Shams Y-Hassan; Per Tornvall
Journal:  Clin Auton Res       Date:  2017-09-15       Impact factor: 4.435

5.  Pheochromocytoma and stress cardiomyopathy: Insight into pathogenesis.

Authors:  Sahil Agrawal; Jamshid Shirani; Lohit Garg; Amitoj Singh; Santo Longo; Angelita Longo; Mark Fegley; Lauren Stone; Muhammad Razavi; Nicoleta Radoianu; Sudip Nanda
Journal:  World J Cardiol       Date:  2017-03-26

Review 6.  Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses?: A Systematic Analytical Review.

Authors:  Marie Batisse-Lignier; Bruno Pereira; Pascal Motreff; Romain Pierrard; Christelle Burnot; Charles Vorilhon; Salwan Maqdasy; Béatrice Roche; Francoise Desbiez; Guillaume Clerfond; Bernard Citron; Jean-René Lusson; Igor Tauveron; Romain Eschalier
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

7.  Takotsubo Cardiomyopathy: A Long Term Follow-up Shows Benefit with Risk Factor Reduction.

Authors:  Koroush Khalighi; Mohammad Umar Farooq; Thein Tun Aung; Swe Oo
Journal:  J Cardiovasc Dev Dis       Date:  2015-11-16

8.  Copy number variants implicate cardiac function and development pathways in earthquake-induced stress cardiomyopathy.

Authors:  Cameron J Lacey; Kit Doudney; Paul G Bridgman; Peter M George; Roger T Mulder; Julie J Zarifeh; Bridget Kimber; Murray J Cadzow; Michael A Black; Tony R Merriman; Klaus Lehnert; Vivienne M Bickley; John F Pearson; Vicky A Cameron; Martin A Kennedy
Journal:  Sci Rep       Date:  2018-05-15       Impact factor: 4.379

Review 9.  Association of Endocrine Conditions With Takotsubo Cardiomyopathy: A Comprehensive Review.

Authors:  Sonali Gupta; Pradeep Goyal; Sana Idrees; Sourabh Aggarwal; Divyansh Bajaj; Joseph Mattana
Journal:  J Am Heart Assoc       Date:  2018-10-02       Impact factor: 5.501

10.  Reverse takotsubo cardiomyopathy- life-threatening symptom of an incidental pheochromocytoma: a case report.

Authors:  Johannes Mierke; Tobias Loehn; Axel Linke; Karim Ibrahim
Journal:  Eur Heart J Case Rep       Date:  2019-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.